市场调查报告书
商品编码
1235929
全球软组织修復市场:到 2028 年的预测——按类型(组织贴片、组织固定产品、腹腔镜器械、其他类型)、应用、最终用户、地区Soft Tissue Repair Market Forecasts to 2028 - Global Analysis By Type (Tissue Patch, Tissue Fixation Products, Laparoscopic Instrument and Other Types), Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球软组织修復市场预计将在 2022 年达到 136 亿美元,到 2028 年达到 201 亿美元,预测期内的复合年增长率为 6.7%,有望实现增长。
软组织损伤会损伤肌肉、韧带和肌腱,引起炎症和疼痛。 软组织修復是通过用健康组织替换受伤或损坏的组织来完成的。 目前的治疗通常依赖于成功率低的手术。 因此,需要创新和先进的治疗方法,例如微创手术和快速癒合产品。
在美国,每年约有 350 万儿童和青少年遭受运动损伤,预计这将推动软组织修復市场的增长。 根据美国运动医学杂誌,ACL 损伤的发生率为每年每 100,000 人中有 68.6 人。
老年人口的增长表明对骨科手术的需求不断增长。 跌倒和事故造成伤害的频率越来越高,预计将导致全球创伤手术数量的增加。 因此,日益老龄化的人口正在推动市场的增长。
产品进入临床试验阶段所需的成本和时间非常高,批准的可能性非常低。 软组织修復产品属于 3 类产品,必须严格遵守监管指南。 因此,即使进行大量投资,也存在很高的失败风险,阻碍了市场的扩张。
人们越来越意识到运动和身体活动有益于您的健康。 正因为如此,这项运动越来越受到年轻人的欢迎。 随着参与运动的增加,与运动相关的软组织损伤正在增加,推动了市场的增长。
我们产品的价格竞争非常激烈。 许多软组织修復产品的高成本限制了它们的采用。 目前的商业产品由复杂的重组组成,保质期很短。 因此,这些阻碍了市场的增长。
COVID-19 大流行对软组织修復市场产生了重大影响。 危机和由此导致的停工对各行各业的运营和经济产生了严重影响。 由于医疗保健服务中断的增加,尤其是对伤口患者的护理,以及伤口护理提供方式的重大变化,市场也感受到了爆发的热度。 然而,预计在大流行期间,不仅对受影响患者的皮肤而且对因压力造成的软组织损伤的担忧也会增加。
由于软组织修復手术的增加,预计疝气修復领域将实现有利可图的增长。 由于许多其他因素的影响,例如对改进网格的需求不断增长、机器人手术的使用增加以及对改进网格的需求,正在推动这一领域的增长。
由于选择诊所接受优质医疗服务的患者激增,预计诊所部分在预测期内将以最快的复合年增长率增长。 此外,由于许多诊所强调需要提供具有成本效益、高质量和个性化的服务,因此产品采用率预计会增加。
由于对医疗技术的需求不断增加、健康意识不断增强以及与骨科疾病患病率上升相关的老龄化率不断上升,预计亚太地区在预测期内将占据最大的市场份额。 此外,本地医疗设备製造商的渗透正在取得进展,为该地区的市场创造了重要的增长机会。
由于对软组织修復产品的需求增加,预计北美在预测期内的复合年增长率最高。 不断上涨的医疗保健成本和对医疗保健基础设施的投资使得昂贵的骨科软组织修復手术变得更加负担得起,从而推动了该地区的增长。
软组织修復市场的主要参与者是: Allergan Plc.、Smith & Nephew PLC、Stryker Corporation、Medtronic Plc.、Zimmer Biomet Holdings, Inc.、Integra LifeScience Corporation、Isto Biologics、Organogenesis Inc.、Depuy Synthes、Wright Medical Group, Inc、Lifenet Health、 Inc.., American Medical Systems Inc., CryoLife, Inc., Arthrex, Inc., S. Stem Cell, Inc., R. Bard, Inc., LifeCell International Pvt. Ltd., Johnson & Johnson Private Limited, Boston Scientific Corporation 和 Athersys. Inc.
2021 年 1 月,Smith & Nephew 将收购 Integra Lifesciences Holdings Corporation 的高度骨科业务。
2019 年 12 月,美敦力 (Medtronic) 的 Dextile Anatomical Mesh 获得了美国 FDA 的批准。 这种疝气修復网可广泛覆盖肌果胶开口,最大限度地降低復发风险并在通过套管针后保持形状。
购买此报告的客户将免费获得以下定制之一。
According to Stratistics MRC, the Global Soft Tissue Repair Market is accounted for $13.6 billion in 2022 and is expected to reach $20.1 billion by 2028 growing at a CAGR of 6.7% during the forecast period. Soft tissues injuries involve harm to the muscles, ligaments and tendons that will result in the inflammation as well as pain. Soft tissue repair is accomplished by replacing injured or damaged tissues with healthy tissues. The current treatment options are heavily reliant on surgical methods with a low success rate. As a result, prevalent, innovatively advanced options such as minimally invasive processes and rapid healing products are critical.
According to estimates, approximately 3.5 million sports injuries occur in children and teenagers in the United States each year which is further anticipated to propel the growth of the soft tissue repair market. According to the American Journal of Sports Medicine, the incidence of ACL injury is 68.6/100,000 individuals per year.
The growing geriatric population indicates that need for orthopaedic procedures would increase. The rising frequency of trauma injuries and injuries from falls and accidents is predicted to increase the number of trauma operations done globally. Hence, growing geriatric population is propelling the market growth.
The cost and time needed for a product to enter the clinical trial stage are very high, with very low prospects of approval. Soft tissue repair products are classified as class 3 products, which necessitate stringent adherence to regulatory guidelines. Therefore, despite significant investments, there is a high risk of failure, which is hindering the market expanding.
There is a growing awareness of the health advantages of sports and physical activity. This has increased the popularity of sports among the youth. With the increasing sports participation, the number of sport related soft tissue injuries is increased, which is propelling the growth of the market.
The products are extremely competitive in terms of pricing. The adoption of many soft tissue repair products is limited due to their high cost. The products currently available on the market are made of complicated reconstitutions with a poor shelf life. Hence, these are the prospects hampering the market growth.
The pandemic of COVID-19 has had a huge impact on the soft tissue repair market. The crisis and the ensuing lockdowns had severe operational and economic consequences across the industrial spectrum. The market also felt the heat of the outbreak as a result of rising disruptions in health care services, particularly the care of patients with wounds, which resulted in significant shifts in the delivery of wound care. However, the concerns over pressure-induced skin as well as soft tissue injuries in the affected patients is expected to rise in the pandemic.
The hernia repair segment is estimated to have a lucrative growth, due to increase in soft tissue repair surgeries. It is expanding as a result of numerous additional factors, including increased need for improved mesh, increased usage of robotic operations, and the desire for improved mesh, which is boosting the segment's growth.
The clinics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the surging number of patient's preference for clinics for quality care. Furthermore, the majority of clinics are emphasising the need of providing cost-effective, high-quality, and individualised services, which is anticipated to increase product adoption.
Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing demand for medical technology, growing health awareness, and growing aging population coupled with the rising prevalence of orthopedic diseases. Higher penetration of local manufacturers of medical devices is providing significant growth opportunities for the market in the region.
North America is projected to have the highest CAGR over the forecast period, owing to rise in the demand for soft tissue repair products. Rising healthcare expenditure and investments in healthcare infrastructure as an increase in healthcare spending can help make expensive orthopedic soft tissue repair surgeries more affordable which is boosting the growth of the region.
Some of the key players profiled in the Soft Tissue Repair Market include: Allergan Plc., Smith & Nephew PLC, Stryker Corporation, Medtronic Plc., Zimmer Biomet Holdings, Inc., Integra LifeScience Corporation, Isto Biologics, Organogenesis Inc., Depuy Synthes, Wright Medical Group, Inc., Lifenet Health, Inc., American Medical Systems Inc., CryoLife, Inc., Arthrex, Inc., S. Stem Cell, Inc., R. Bard, Inc., LifeCell International Pvt. Ltd., Johnson & Johnson Private Limited, Boston Scientific Corporation and Athersys Inc.
In January 2021, Smith & Nephew acquires the extremely Orthopaedics business of Integra Lifesciences Holdings Corporation.
In December 2019, Medtronic received U.S FDA approval for its Dextile Anatomical Mesh. This hernia repair mesh provides wide coverage of the myopectineal orifice to minimize the risk of recurrence and maintain shape after trocar passage.
All the customers of this report will be entitled to receive one of the following free customization options:
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.